Application of dual-energy spectrum CT in the evaluation of microcirculation disorders in type 2 diabetes mellitus

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054491

Enrollment

Unknown

Registered

2021-12-18

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

prediabetes group:none

type 2 diabetes :none

normal :none

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, no gender limit. 2. Abnormal glucose metabolism, such as impaired fasting blood glucose, impaired glucose tolerance and diabetes mellitus (in line with the 2019 WHO diagnostic criteria). 3. Voluntarily participate in this research and sign the relevant informed consent.

Exclusion criteria

Exclusion criteria: 1. Acute infection, ketoacidosis and other serious complications. 2. Known or possible hypersensitivity to iodinated contrast media. 3. Known diseases such as pancreatitis, pancreatic cysts and pancreatic tumors. 4. Inability to complete general information collection or tolerance OGTT test. 5. Pregnant patients. 6. Combined with mental illness and cognitive dysfunction and unable to take care of themselves. 7. Type 1 diabetes or other special type of diabetes.

Design outcomes

Primary

Measure	Time frame
Standard iodine concentration;	—

Secondary

Measure	Time frame
Glycated hemoglobin;Blood lipids;	—

Countries

China

Contacts

Public ContactWang Wei

Longyan First Hospital

591187650@qq.com+86 17704610659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026